-

BIOQUAL Declares Dividend

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL’s Board of Directors has declared a dividend of $0.50 per share for shareholders of record on October 6, 2023, payable on October 27, 2023. This is the twenty-second dividend declared by BIOQUAL.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to obtain sufficient numbers of animal models; the availability of adequate numbers of employees; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.

Contacts

Mark G. Lewis, Ph.D., CEO (240-404-7654)

BIOQUAL, Inc.

OTC Pink:BIOQ

Release Versions

Contacts

Mark G. Lewis, Ph.D., CEO (240-404-7654)

More News From BIOQUAL, Inc.

BIOQUAL Announces the retirement of Dr. Mark G. Lewis as President and CEO of the company

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets): Dr. Mark Lewis will be retiring as President of BIOQUAL effective May 31, 2025, and is succeeded by Dr. Hanne Andersen Elyard, BIOQUAL’s Chief Science Officer. Dr. Lewis will remain as Chairman of the Board of Directors. Dr. Lewis joined BIOQUAL as Senior Scientist in August 2003. He became the Executive Vice President in October 2008 and served in that capacity until he became President and CEO in 2010. “The entir...

BIOQUAL Announces Retirement of Mike O'Flaherty From Board

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. www.bioqual.com BIOQ(Pinksheets) BIOQUAL, Inc., announced today that Mr. Michael P. O’Flaherty will retire from his role as a BIOQUAL Board Member effective May 1, 2025. Mr. O’Flaherty served as the Chief Operating Officer and Secretary of the Corporation until he retired in 2015 at which time he was elected to the BIOQUAL Board. Mr. O’Flaherty is 86 years old and has served as a Director since 2015. His retirement is not connected to any disagreem...

BIOQUAL Presents Unaudited Financial Results for Third Quarter of Fiscal Year 2025

ROCKVILLE, Md.--(BUSINESS WIRE)--BIOQUAL, Inc. (OTC Pink: BIOQ) www.bioqual.com:   Nine Months Ended Three Months Ended   February 28 & 29, February 28 & 29,     2025     2024   2025   2024   Revenue $ 37,198,902   $ 46,792,353 $ 14,032,982 $ 15,344,027     (Loss) Income Before Income Tax $ (1,312,897 ) $ 2,288,970 $ 1,291,330 $ 379,226     Net (Loss) Income $ (951,497 ) $ 1,659,170 $ 936,030 $ 275,026     Basic Earnings per Share   of Common Stock $ (1.06 ) $ 1.86 $ 1.05 $ 0.31     Dil...
Back to Newsroom